Pradžia › Glioma › Masčusetsas › Boston
Glioma klinikiniai tyrimai Boston, MA
20 tyrimai dėl Glioma ieško dalyvių vietose Boston ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
MCT for the Harvard/UCSF ROBIN Center
Renkami dalyviai
- Brigham and Women's Hospital, Boston
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Renkami dalyviai1/2 fazė
- Dana-Farber Cancer Institute, Boston
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Renkami dalyviai2 fazė
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Renkami dalyviai1/2 fazė
- Dana Farber Cancer Institute., Boston
Targeted Pediatric High-Grade Glioma Therapy
Renkami dalyviaiStebimasis tyrimas
- Dana-Farber Cancer Institute, Boston
Study of Olutasidenib and Temozolomide in HGG
Renkami dalyviai2 fazė
- Susan Chi, Boston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Renkami dalyviai3 fazė
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Renkami dalyviai2 fazė
- Dana-Farber Cancer Institute, Boston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Renkami dalyviai1/2 fazė
- Research Site, Boston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Renkami dalyviai2 fazė
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
CARv3-TEAM-E T Cells in Glioblastoma
Renkami dalyviai1 fazė
- Massachusetts General Hospital Cancer Center, Boston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Renkami dalyviaiAnkstyvoji 1 fazėLaukiami sveiki savanoriai
- Dana-Farber Cancer Institute, Boston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Renkami dalyviai2 fazė
- Dana-Farber Cancer Institute, Boston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Renkami dalyviai1/2 fazė
- Dana Farber Cancer Institute, Boston
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Renkami dalyviaiAnkstyvoji 1 fazė
- Dana-Farber Cancer Institute, Boston
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
Renkami dalyviai1 fazė
- Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston
CUE-102 in Recurrent Glioblastoma
Renkami dalyviai1 fazė
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
NeuroPathways Intervention for Brain Tumor Patients
Renkami dalyviai
- Massachusetts General Hospital Cancer Center, Boston
ASCENT Intervention for Brain Tumor Patients
Renkami dalyviai
- Massachusetts General Hospital Cancer Center, Boston
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Renkami dalyviaiStebimasis tyrimas
- Massachusetts General Hospital, Boston
Glioma tyrimai kituose miestuose
- New York City, NY25 tyrimai
- Houston, TX23 tyrimai
- Washington, DC19 tyrimai
- Philadelphia, PA16 tyrimai
- Miami, FL15 tyrimai
- Columbus, OH15 tyrimai
- San Francisco, CA14 tyrimai
- Chicago, IL13 tyrimai
- Durham, NC12 tyrimai
- Seattle, WA11 tyrimai
- Los Angeles, CA10 tyrimai
- St. Louis, MO10 tyrimai
Kiti tyrimai Boston
- Krūties vėžys111 tyrimai
- Nedidelinių ląstelių plaučių vėžys90 tyrimai
- Vėžys (visų tipų)86 tyrimai
- Storosios ir tiesiosios žarnos vėžys63 tyrimai
- Metastatinis vėžys63 tyrimai
- Plaučių vėžys62 tyrimai
- Kiaušidžių vėžys61 tyrimas
- Prostatos vėžys59 tyrimai
- Depresija52 tyrimai
- Endometrio vėžys50 tyrimai
- Širdies nepakankamumas44 tyrimai
- Ūmi mieloidinė leukemija44 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.